GGD Amsterdam

SHM contributes to the MSM Observational Study of Acute Infection with Hepatitis C (MOSAIC) study coordinated by the GGD Amsterdam. The MOSAIC study involves a cohort of men who have sex with men (MSM) with chronic HIV infection who have contracted an acute hepatitis C (HCV) infection. The aims of the study are to look at how this group contributes to the transmission of HIV; to explore the driving factors of the HCV epidemic and HIV’s role in it; and to examine the impact of acute HCV infection, reinfection and treatment on disease progression.

SHM and GGD Amsterdam also work together on the Amsterdam Cohort Studies in collaboration with the AMC-UvA. The ACS are primarily funded through the RIVM-CIb. Since 2015, ACS funding has been included in the structural institute grant awarded to SHM by the ministry of Health, Welfare and Sport through the RIVM-CIb.

Finally, the GGD participated in the aMASE study, which was part of EuroCoord. This study aimed to identify barriers that migrant communities face when accessing healthcare, so that HIV prevention, diagnosis and prognosis may be improved in migrants in Europe. SHM provided clinical data required for the Netherlands’ part of the study. aMASAE was part of EuroCoord, the collaboration that encompassed all EU-funded cohort studies in the field of HIV and that ended in 2015. For the time being, scientific productivity within aMASE is continuing based on the last available joint dataset.